CUSIP: 00507W107
Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
22,526,710
-
Share change
-
+12,893,798
-
Total reported value
-
$8,223,000
-
Price per share
-
$0.37
-
Number of holders
-
35
-
Value change
-
+$4,689,851
-
Number of buys
-
19
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP 00507W107?
CUSIP 00507W107 identifies ATNM - ACTINIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2018
-
Previous quarter:
Q4 2017
Recent filing periods for CUSIP 00507W107:
Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q1 2018
As of 31 Mar 2018,
ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,526,710 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Anson Funds Management LP, DLD Asset Management, LP, VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, Sio Capital Management, LLC, CREDIT SUISSE AG/, BlackRock Inc., Worth Venture Partners, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.